2016 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
12/28/16West to Present at J.P. Morgan Healthcare Conference
EXTON, Pa., Dec. 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of the Company's business at the 35th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, at 3:30 p.m. PT on Wednesday, January 11, 2017. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. ... 
Printer Friendly Version
12/20/16West Pharmaceutical Services' Karen Flynn Receives Silver Stevie® Award in 2016 Stevie Awards for Women in Business
Flynn recognized in the Female Executive of the Year category for her instrumental role in developing and executing West's market-led, long-term strategic plan EXTON, Pa., Dec. 20, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that Senior Vice President and Chief Commercial Officer Karen Flynn has been named the winner of a Silver Stevie® Award in the Female Execut... 
Printer Friendly Version
12/15/16West Receives Global Industry Recognitions for Innovative Contributions to Pharmaceutical Packaging and Drug Delivery
Company honored with 2016 India Pharma Award and Irish Medtech Excellence Award; West's SmartDose® platform takes second place in Medicine Maker Innovation Awards EXTON, Pa., Dec. 15, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced it has received multiple honors for innovation in the pharmaceutical industry including the 2016 UBM India Pharma Award for "Leading Comp... 
Printer Friendly Version
12/14/16West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa., Dec. 14, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017, to shareholders of record as of January 18, 2017. The Company also announced a share repurchase program authorizing the repurchase of up to 800,000 shares of the Company's common stock from time to time on the ... 
Printer Friendly Version
11/29/16West Announces Expanded Contract Manufacturing Capabilities in Ireland
Adds to Growing Manufacturing Footprint in Ireland DUBLIN, Nov. 29, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract manufacturing facility near Mulhuddart, County Dublin. The expansion is in response to customer demand for medical device manufacturing—especially in the area of diabetes—and represents West's most rec... 
Printer Friendly Version
10/27/16West Announces Third Quarter 2016 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., Oct. 27, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for full-year 2017 and reaffirmed long-term 2020 financial targets.  Third Quarter 2016 Highlights Reported net sales of $376.7 million grew 9.4% over the prior-year quarter. Net sales at constan... 
Printer Friendly Version
10/17/16West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices
Two co-presentations with Amgen highlight West's approach to delivering innovative drug delivery solutions for its customers HUNTINGTON BEACH, Calif., Oct. 17, 2016 /PRNewswire/ -- (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it will participate in several educational sessions, scientific posters, and presentations at the 2016 PDA Universe of Pre-filled Syringes &... 
Printer Friendly Version
10/13/16West to Host Third Quarter 2016 Conference Call
EXTON, Pa. , Oct. 13, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before the market opens on Thursday, October 27, 2016 , and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time . To participate on the call please dial 877-930-8295 (... 
Printer Friendly Version
09/26/16West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain
EXTON, Pa., Sept. 26, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice President, Global Operations and Supply Chain, effective September 26, 2016. Mr. Montecalvo will serve on the senior leadership team and will oversee the Company's Global Operations function.  Mr. Montecalvo joins West from Medtronic plc, where he se... 
Printer Friendly Version
09/12/16West Elects New Director and Announces Increase to Quarterly Dividend
EXTON, Pa., Sept. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy following the retirement of Anthony Welters.    Mr. Pucci, 54, is Chief Executive Officer of ArQule, Inc., a biopharmaceutical company engaged in the research and development of targeted therapeutics. Prior to his joining ArQule in 2008, Mr. Pucci worked at Bayer A.G., where he served in a number of leaders... 
Printer Friendly Version
09/02/16West to Present at Three Healthcare Conferences in September
EXTON, Pa., Sept. 2, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at three investor conferences in September.  Management will present at the Baird 2016 Global Healthcare Conference, New York, New York, at 8:30 a.m. EDT on Wednesday, September 7, 2016; the 2016 Wells Fargo Healthcare Conference, Boston, Massachusetts, at 11:05 a.m. EDT on Thursday, September 8, 2016; and the Morgan Stan... 
Printer Friendly Version
07/28/16West Announces Second Quarter 2016 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., July 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016.  Second Quarter 2016 Highlights Reported net sales of $388.0 million grew 7.9% over the prior-year quarter.  Net sales at constant currency grew by 8.2%. Second quarter 2016 reported diluted EPS was $0.60 as compared to $... 
Printer Friendly Version
07/14/16West to Host Second Quarter 2016 Conference Call
EXTON, Pa., July 14, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second quarter 2016 financial results before the market opens on Thursday, July 28, 2016, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International). ... 
Printer Friendly Version
07/11/16West's SmartDose® Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System
On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) EXTON, Pa., July 11, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the U.S. Food and Drug Administration (FDA) has approved the first combination product that incorporates its SmartDose® technology for use in the United States. Amgen announced FDA approval for a single, monthly... 
Printer Friendly Version
07/05/16West Announces Quarterly Dividend
EXTON, Pa., July 5, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0.12 per share. The dividend will be paid on August 3, 2016, to shareholders of record as of July 20, 2016. About West West Pharmaceutical Services, Inc., is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its cust... 
Printer Friendly Version
06/07/16West Introduces 1-3mL NovaPure® Plunger for Higher Volume Injections
New, high-quality plungers launched at the 2016 BIO International Convention EXTON, Pa., June 7, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure® plunger—an innovative, high-quality component for pre-filled delivery systems, designed to reduce particulate, ensure consistency of delivery and fit the changing needs of higher-volume injectable ... 
Printer Friendly Version
06/01/16West to Present at Investor Conference in June
EXTON, Pa., June 1, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY, on Wednesday, June 8, 2016 at 11:30 a.m. EDT. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. About West West Pharmaceutical Services, Inc., is a leading ... 
Printer Friendly Version
05/04/16West to Present at Two Investor Conferences in May
EXTON, Pa., May 4, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health Care Conference, Las Vegas, Nevada, on Wednesday, May 11, 2016, at 1:40 p.m. PDT and at the UBS Global Healthcare Conference, New York, New York, on Tuesday, May 24, 2016, at 4:00 p.m. EDT. A live audio webcast o... 
Printer Friendly Version
04/28/16West Announces First Quarter 2016 Results
- Reports Quarterly Sales of $362 Million, Constant-Currency Sales Growth of 10.5% and Adjusted Diluted EPS of $0.53. - Raises Lower-end of Full-year 2016 Sales and Adjusted EPS Guidance Ranges. - Conference Call Scheduled for 9 a.m. EDT Today. EXTON, Pa., April 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter 2016 and updated financial guidance for the full-year 2016.  First Quarter 2016 Highligh... 
Printer Friendly Version
04/25/16West Makes Investment in NanoPass Technologies
EXTON, Pa., April 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. This investment will provide West with access to NanoPass' knowledge and expertise in the growing area of intradermal drug delivery and future collaboration opportunities to bring new products to market. West's investment will also allow NanoPass to advance its cl... 
Printer Friendly Version
04/14/16West to Host First Quarter 2016 Conference Call
EXTON, Pa., April 14, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first quarter 2016 financial results before the market opens on Thursday, April 28, 2016, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International).... 
Printer Friendly Version
03/04/16West Announces Quarterly Dividend
EXTON, Pa., March 4, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share. The dividend will be paid on May 4, 2016, to shareholders of record as of April 20, 2016. About West West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its cust... 
Printer Friendly Version
03/01/16West Appoints Eric Resnick to Chief Technology Officer
John Paproski to Retire After 36 Years of Service EXTON, Pa., March 1, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric Resnick has been appointed to serve as Vice President and Chief Technology Officer, succeeding John Paproski, who plans to retire on April 1, 2016. Mr. Resnick will be responsible for leading the Company's Innovation and Technology Team, which has been estab... 
Printer Friendly Version
02/25/16West to Host Analyst and Investor Day
EXTON, Pa., Feb. 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company will host an Analyst and Investor Day on Thursday, March 10, 2016, from 8:30 a.m. to 12 p.m. EST in New York, NY. Members of West's senior management team will provide an overview of the Company's markets; its Commercial, Global Operations, Innovation & Technology and Finance groups; and growth o... 
Printer Friendly Version
02/18/16West Announces Fourth Quarter and Full-Year 2015 Results
Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47 -- Annual Sales of $1.4 Billion Generated Adjusted Diluted EPS of $1.83 in 2015 -- Reaffirms 2016 Guidance for 6% to 8% Growth in Net Sales at Constant Currency -- Provides Full-Year 2016 Adjusted Diluted EPS Guidance in the Range of $2.10 to $2.25 -- Conference Call Scheduled for 9 a.m. EST Today EXTON, PA -- (Marketwired) -- 02/18/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial res... 
Printer Friendly Version
02/12/16West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen
High-performance containment system selected by top biotech company EXTON, Pa., Feb. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that global biotechnology leader Amgen Inc. has utilized West's Daikyo Crystal Zenith® (CZ) vials, in conjunction with West FluroTec® stoppers, to contain its FDA-approved therapy IMLYGIC™ (talimogene laherparepvec). Manufactured from a cyclic o... 
Printer Friendly Version
02/11/16West to Host Fourth Quarter and Full Year 2015 Conference Call
EXTON, PA -- (Marketwired) -- 02/11/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2015 financial results before the market opens on Thursday, February 18, 2016, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 48925428. A live broadcast of the c... 
Printer Friendly Version
02/03/16West to Present at LEERINK Conference
EXTON, PA -- (Marketwired) -- 02/03/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at the LEERINK Partners 5th Annual Global Healthcare Conference, New York, NY at 10:40 a.m. ET on Wednesday, February 10th, 2016. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. About West West Pharmaceutical ... 
Printer Friendly Version
01/20/16West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems
Presentation at Drug Delivery Partnerships 2016 will offer best practices for effective patient onboarding with wearable self-injection systems EXTON, Pa., Jan. 20, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug containment and delivery, today announced that the company is collaborating with Noble®, a leader in patient-centric onboarding and training, to provide multisensory-based educational and training prog... 
Printer Friendly Version
01/12/16West Announces New Organizational Structure
EXTON, Pa., Jan. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will support the Company in its next phase of growth and development. Beginning in 2016, the company will no longer operate two separate units for its Packaging and Delivery System businesses. West is establishing global Commercial, Operations and Innovation &... 
Printer Friendly Version
01/06/16West to Present at J.P. Morgan Conference
EXTON, PA -- (Marketwired) -- 01/06/16 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 34rd Annual J.P. Morgan Healthcare Conference, San Francisco, CA at 3:00 p.m. PT on Wednesday, January 13th, 2016. A live audio webcast of the presentation, as well as the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/investors. About West West Pharmaceut... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations